2m 2m 2m 2m 2m 2m 2m
HEALTH CATALYST (HCAT)
NASDAQ
$1.33$0.00 (0.00%)
Price as of Jun 03, 2026 4:10 PM EDT- $102.0MMarket Cap
- -66.58%1-Year Change
- Health Information ServicesIndustry
HEALTH CATALYST (HCAT)
$1.33$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 208.3M -32.07% | 306.6M +3.60% | 295.9M +7.13% | 276.2M +14.18% | |
Cost of Revenue | 69.7M -57.94% | 165.8M +1.04% | 164.1M +14.72% | 143.0M +15.03% | |
Gross Profit | 140.3M +8.65% | 129.1M +1.09% | 127.7M +4.47% | 122.3M +19.50% | |
Sales and Marketing Expense | 52.5M -3.51% | 54.4M -19.21% | 67.3M -23.07% | 87.5M +16.64% | |
Research and Development Expense | -49.8M -14.12% | -58.0M -20.21% | -72.6M -4.03% | -75.7M +20.64% | |
Depreciation and Amortization Expense | 50.5M +21.89% | 41.4M -1.88% | 42.2M -12.58% | 48.3M +28.70% | |
Total Operating Expenses | 312.5M +48.41% | 210.6M -18.61% | 258.7M -5.29% | 273.2M +4.58% | |
Operating Profit | -160.9M +130.43% | -69.8M -44.99% | -126.9M -9.36% | -140.0M -2.54% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -16.4M +2,475.20% | -637,000 -91.26% | -7.3M +0.66% | -7.2M -59.10% | |
Interest Income and Expense and Net | -16.4M +2,475.20% | -637,000 -91.26% | -7.3M +0.66% | -7.2M -59.10% | |
Total Nonoperating Income and Expense | -16.4M -2,675.20% | 637,000 -91.26% | 7.3M +0.66% | 7.2M -59.10% | |
Income before Taxes | -177.3M +156.27% | -69.2M -41.28% | -117.8M -16.86% | -141.7M -11.51% | |
Income Taxes | 716,000 +115.02% | 333,000 -6.46% | 356,000 +108.32% | -4.3M -37.95% | |
Extraordinary Items | 0 N/A | 0 -100.00% | 600,000 -50.00% | 1.2M N/A | |
Net Income | -178.0M +156.07% | -69.5M -41.17% | -118.1M -14.01% | -137.4M -10.32% | |
Net Income from Continuing Operations Applicable to Common | -178.0M +156.07% | -69.5M -41.17% | -118.1M -14.01% | -137.4M -10.32% | |
Basic EPS and Net Income | -2.55 +121.74% | -1.15 -44.98% | -2.09 -18.36% | -2.56 -20.74% | |
Diluted EPS and Net Income | -2.55 +121.74% | -1.15 -44.98% | -2.09 -20.53% | -2.63 -18.58% | |
Basic Weighted Average Shares | 69.9M +16.14% | 60.2M +6.68% | 56.4M +5.02% | 53.7M +13.11% | |
Diluted Weighted Average Shares | 69.9M +16.14% | 60.2M +6.68% | 56.4M +4.32% | 54.1M +13.86% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 50.8M -79.65% | 249.6M +134.90% | 106.3M -8.63% | 116.3M -39.81% | |
Short-Term Investments | 44.9M -68.45% | 142.4M -32.68% | 211.5M -14.45% | 247.2M -1.82% | |
Cash and Cash Equivalents and Short-Term Investments | 95.7M -75.58% | 392.0M +23.38% | 317.7M -12.59% | 363.5M -18.31% | |
Total Current Assets | 169.3M -63.64% | 465.6M +18.37% | 393.4M -8.04% | 427.8M -15.85% | |
Accumulated Depreciation | 53.3M +35.41% | 39.4M +43.96% | 27.4M +56.71% | 17.5M +52.69% | |
Property and Plant and Equipment and Net | 33.8M +15.12% | 29.4M +14.32% | 25.7M -0.83% | 25.9M +11.20% | |
Total Long-Term Assets | 6.1M +1.51% | 6.0M +26.87% | 4.7M +27.00% | 3.7M -16.95% | |
Total Assets | 502.6M -41.48% | 858.9M +22.39% | 701.8M -6.71% | 752.3M -9.59% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.6M -99.30% | 231.2M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 89.6M -72.51% | 325.9M +265.98% | 89.0M +7.91% | 82.5M -11.33% | |
Total Long-Term Debt | 151.6M +0.30% | 151.2M -33.70% | 228.0M +0.67% | 226.5M +25.19% | |
Total Long-Term Liabilities | 798,000 +418.18% | 154,000 +108.11% | 74,000 -38.84% | 121,000 +7.08% | |
Total Liabilities | 256.9M -47.97% | 493.7M +47.43% | 334.9M +2.33% | 327.3M +5.57% | |
Retained Earnings | -1.4B +15.00% | -1.2B +6.22% | -1.1B +11.83% | -999.0M +13.67% | |
Total Stockholders Equity | 245.8M -32.70% | 365.2M -0.47% | 366.9M -13.67% | 425.0M -18.60% | |
Total Shares Outstanding | 72.0M +12.47% | 64.0M +9.86% | 58.3M +5.49% | 55.3M +5.02% | |
Cash Flow | |||||
Cash from Operating Activities | 731,000 -94.98% | 14.6M +144.01% | -33.1M -6.21% | -35.3M +52.53% | |
Capital Expenditures | 968,000 -40.10% | 1.6M +30.74% | 1.2M -42.96% | 2.2M -79.26% | |
Cash from Investing Activities | 36.2M +258.03% | -22.9M -212.86% | 20.3M +152.01% | -39.0M -72.06% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -235.8M -255.38% | 151.7M +5,458.46% | 2.7M +204.48% | -2.6M -100.99% | |
Financials Ratio | |||||
Gross Margin | 66.52% +44.85% | 45.92% +3.08% | 44.55% -7.61% | 48.21% -0.79% | |
Operating Margin | -77.23% +239.19% | -22.77% -46.90% | -42.88% -15.40% | -50.68% -14.64% | |
Return on Assets | -26.14% +193.53% | -8.91% -45.19% | -16.25% -6.31% | -17.34% -20.20% | |
Return on Equity | -58.26% +206.84% | -18.99% -36.37% | -29.84% +2.83% | -29.02% -24.42% | |
Revenue Growth | -32.07% -991.35% | 3.60% -49.56% | 7.13% -49.71% | 14.18% -49.54% | |
Current Ratio | 1.89 +32.27% | 1.43 -67.66% | 4.42 -14.78% | 5.18 -5.10% | |
Cash Ratio | 0.57 -25.95% | 0.77 -35.82% | 1.19 -15.32% | 1.41 -32.11% | |
Debt-to-Equity Ratio | 0.62 -40.45% | 1.05 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.30 -31.51% | 0.45 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow